Inventor · disambiguated record
Tom Yao-Hsiang Wu
Also filed as: WU TOM · WU TOM YAO-HSIANG
29 granted patents·12 pending applications·163 citations·filing 2003–2024
95Inventor score
Top patents by PatentIndex Score
41 records- 0192US9902730B2Compounds and compositions as toll-like receptor 7 agonistsNOVARTIS AG·Filed 2015·Granted Feb 27, 2018·36 cites·18 claims
- 0290US9944649B2Compounds and compositions as toll-like receptor 7 agonistsCORTEZ ALEX·Filed 2015·Granted Apr 17, 2018·17 cites·19 claims
- 0389US7205328B2Oxindoles with anti-HIV activityIRM LLC·Filed 2003·Granted Apr 17, 2007·25 cites·24 claims
- 0487US9045470B2Compounds and compositions as TLR activity modulatorsWU TOM YAO HSIANG·Filed 2010·Granted Jun 2, 2015·15 cites·7 claims
- 0587US8466167B2Compounds and compositions as TLR activity modulatorsWU TOM YAO HSIANG·Filed 2009·Granted Jun 18, 2013·16 cites·26 claims
- 0686US10287253B2Substituted pyrimidines containing acidic groups as TLR7 modulatorsAPROS THERAPEUTICS INC·Filed 2017·Granted May 14, 2019·3 cites·39 claims
- 0786US7253166B26-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cellsSCRIPPS RESEARCH INST·Filed 2004·Granted Aug 7, 2007·18 cites·6 claims
- 0884US10973826B2Antibody conjugates comprising toll-like receptor agonistCORTEZ ALEX·Filed 2016·Granted Apr 13, 2021·6 cites·28 claims
- 0984US9315530B2Adsorption of immunopotentiators to insoluble metal saltsSINGH MANMOHAN·Filed 2011·Granted Apr 19, 2016·7 cites·18 claims
- 1083US10786502B2Substituted pyrimidines containing acidic groups as TLR7 modulatorsAPROS THERAPEUTICS INC·Filed 2019·Granted Sep 29, 2020·1 cites·31 claims
- 1182US11752162B2Compounds and compositions for treating solid tumors by intratumoral administrationNOVARTIS AG·Filed 2018·Granted Sep 12, 2023·1 cites·21 claims
- 1280US9365506B2Compounds and compositions as TLR2 agonistsWU TOM YAO-HSIANG·Filed 2014·Granted Jun 14, 2016·5 cites·18 claims
- 1380US2025073236A1Pyrimidine compounds containing acidic groupsAPROS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1479US12168646B2Aryl hydrocarbon receptor agonists and uses thereofNEXYS THERAPEUTICS INC·Filed 2024·Granted Dec 17, 2024·0 cites·21 claims
- 1579US7442716B22-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitorsMERCK FROSST CANADA LTD·Filed 2005·Granted Oct 28, 2008·4 cites·27 claims
- 1678US12371408B2Aryl hydrocarbon receptor agonists and uses thereofNEXYS THERAPEUTICS INC·Filed 2024·Granted Jul 29, 2025·0 cites·20 claims
- 1777US8895577B2Compounds and compositions as TLR activity modulatorsWU TOM YAO-HSIANG·Filed 2013·Granted Nov 25, 2014·4 cites·20 claims
- 1876US10857153B2Pyrimidine compounds containing acidic groupsAPROS THERAPEUTICS INC·Filed 2019·Granted Dec 8, 2020·1 cites·10 claims
- 1976US8808703B2Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etcWU TOM YAO-HSIANG·Filed 2011·Granted Aug 19, 2014·4 cites·18 claims
- 2074US2024009215A1Compounds and compositions for treating solid tumors by intratumoral administrationNOVARTIS AG·Filed 2023·Application pending·0 cites
- 2169US2024398776A1Inhibitors of tgf-beta r1 (alk5) useful to treat cell proliferation disordersNEXYS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2266US11173157B2Substituted pyrimidines containing acidic groups as TLR7 modulatorsAPROS THERAPEUTICS INC·Filed 2020·Granted Nov 16, 2021·0 cites·47 claims
- 2365US10844068B2Compounds and compositions as toll-like receptor 7 agonistsNOVARTIS AG·Filed 2019·Granted Nov 24, 2020·0 cites·16 claims
- 2462US2021346387A1Antibody conjugates comprising toll-like receptor agonistNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2557US7943649B22-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitorsMERCK FROSST CANADA LTD·Filed 2008·Granted May 17, 2011·0 cites·7 claims
- 2654US10407431B2Compounds and compositions as toll-like receptor 7 agonistsNOVARTIS AG·Filed 2018·Granted Sep 10, 2019·0 cites·16 claims
- 2753US10098949B2Adsorption of immunopotentiators to insoluble metal saltsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Oct 16, 2018·0 cites·14 claims
- 2852US12102626B2(Pyridin-2-yl)amine derivatives as TGF-BETA R1 (ALK5) inhibitors for the treatment of cancerNEXYS THERAPEUTICS INC·Filed 2019·Granted Oct 1, 2024·0 cites·19 claims
- 2952US2018333406A1Benzonapthyridine compositions and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 3051US2021228713A1Tlr7 peptide conjugatesAPROS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3150US9597326B2Benzonapthyridine compositions and uses thereofOTTEN GILLIS·Filed 2011·Granted Mar 21, 2017·0 cites·15 claims
- 3249US2023053449A1Dc-sign antibody drug conjugatesNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3349US2021170043A1Dc-sign antibody conjugates comprising sting agonistsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3449US2011237622A1Renin inhibitorsMERCK FROSST CANADA LTD·Filed 2009·Application pending·0 cites
- 3546US8343968B2Case of renin inhibitorsMERCK CANADA INC·Filed 2008·Granted Jan 1, 2013·0 cites·15 claims
- 3642US8334308B2Renin inhibitorsJUTEAU HELENE·Filed 2008·Granted Dec 18, 2012·0 cites·11 claims
- 3742US8076359B2Renin inhibitorsDUBE DANIEL·Filed 2007·Granted Dec 13, 2011·0 cites·9 claims
- 3841US8889714B23,4-substituted piperidine derivatives as renin inhibitorsCHEN AUSTIN CHIH-YU·Filed 2009·Granted Nov 18, 2014·0 cites·15 claims
- 3941US2011152316A13,4-substituted piperidine derivatives as renin inhibitorsCHEN AUSTIN CHIH-YU·Filed 2009·Application pending·0 cites
- 4041US2020164084A1Antibody conjugates comprising toll-like receptor agonist and combination therapiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 4137US2015225432A1Compounds and compositions as tlr activity modulatorsCORTEZ ALEX·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tom Yao-Hsiang Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →